TAK compared with GLXY: revenue, margins and what each company keeps, and the suppliers and customers both name

TAKTakeda Pharmaceutical Co Ltd

Mkt capRevenueRevenue

GLXYGalaxy Digital Inc.

Mkt capRevenueRevenue

Compare

TAKTakeda Pharmaceutical Co Ltd

GLXYGalaxy Digital Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TAK1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26±12.8%▼−0.69%×0.05

GLXY2 of 4 reports

1 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26±11.2%▲+9.57%×0.86

Q2 FY26±10.1%▼−13.89%×1.38

= impliedTAK realized, solidGLXY realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

TAKTakeda Pharmaceutical Co Ltd

21.01▼−0.85%· post 21.02

Mkt cap$36.2BRevenue—Revenue—

GLXYGalaxy Digital Inc.

13.65▲+5.17%· post 13.60

ClosedNov 6 '26

Mkt cap$2.6BRevenue$8.7BQ2 FY26Revenue$74.2BFY25

Compare

ClosedNov 6 '26

TAKTakeda Pharmaceutical Co Ltd

GLXYGalaxy Digital Inc.

21.01▼−0.85%post 21.02

Price

13.65▲+5.17%post 13.60

$36.2B

Mkt cap

$2.6B

—

Revenue

$8.7BQ2 FY26

—

Revenue

$74.2BFY25

TAK21.01▼−0.85%vsGLXY13.65▲+5.17%ClosedNov 6 '26